Ifp Advisors, Inc Verona Pharma PLC Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Verona Pharma PLC stock. As of the latest transaction made, Ifp Advisors, Inc holds 547 shares of VRNA stock, worth $57,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
547Holding current value
$57,484% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
294Shares Held
73.9MCall Options Held
933KPut Options Held
1.98M-
Perceptive Advisors LLC New York, NY6.56MShares$690 Million17.44% of portfolio
-
Janus Henderson Group PLC London, X05.52MShares$580 Million0.2% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y93.92MShares$412 Million17.31% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.46MShares$363 Million13.82% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.89MShares$304 Million3.9% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.41B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...